Sigma-Aldrich launches new product, EX-CELL, includes CHOZEN cells

Sangamo receives royalties from Sigma-Aldrich on the sale or licensing of ZFN modified cell lines.
Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that SAFC^® Commercial (www.sigma-aldrich.com/safc), the Company’s business unit providing products and services for use in regulated pharmaceutical and biopharmaceutical applications, has launched the EX-CELL^® Advanced™ product line. Designed to address the needs of an evolving industry where speed to market is paramount, the new product line provides for increased performance, streamlines regulatory compliance, and offers the supply chain security needed in today’s biopharmaceutical environment.
The first EX-CELL Advanced product is the high-performing batch media system developed for a range of widely used industrial CHO cell lines, including SAFC’s proprietary CHOZN^® cell line. During rigorous testing, the EX-CELL Advanced CHO Fed-batch System outperformed other commercially available equivalents by displaying significantly higher titers. Robust scale up and effortless adaptation offers those in biopharmaceutical development the opportunity to get their process up and running quickly and efficiently. Protein quality, another vital consideration in the development process, remains uncompromised